In this study, 12 different indole‐substituted maleimide derivatives were designed, synthesized, and MTT tests were performed in two different breast cancer cell lines (MCF‐7 and MDA‐MB‐231) to determine their GSK‐3β inhibitor activities. The gene discussed is GSK3B; the disease is breast cancer.